Ferrer, Poirot & Wansbrough | Injury Law Blog

10,000 Units of Antibiotic Drug Recalled Due to Contamination

by Keith Adkins | April 15th, 2014

The U.S. Food and Drug Administration (FDA) has been working to improve the safety of medications in the U.S., but they have faced significant hurdles in regulating medications imported into the U.S. due to a lack of ability to enforce safe manufacturing practices.

This problem was highlighted by a massive recall of drugs manufactured in India due to a risk of patients suffering Antibiotic Drug Injuries due to contamination. Reports indicate the recall affected more than 10,000 bottles of the drug.

According to an article from The Economic Times, the medication Suprax is a third-generation antibiotic that is effective in treating many common infections. However, the drug’s manufacturer, Lupin, discovered the sterility of certain lots of the product may have been compromised during the manufacturing process.

The company has since launched a recall of affected medications and is asking anyone who has been harmed as a result of taking the faulty products to come forward to report the incident.

The Drug Injury Attorneys with Ferrer, Poirot & Wansbrough would also encourage anyone who has been harmed as the result of using a recalled product to discuss their legal options with an attorney as soon as possible.

Bookmark and Share

FDA Releases Online Version of The Orange Book

by Keith Adkins | April 8th, 2014

Finding a reliable source of information about medications can be extremely difficult. This lack of detailed medication data often leads to errors in the distribution and administration of a medication, causing serious Drug Injuries.

This leaves many citizens wondering where to find answers to questions about medications. The Drug Injury Attorneys with Ferrer, Poirot & Wansbrough explain that discussing your concerns with your doctor is the best option. But for simple information, the U.S. Food and Drug Administration (FDA) may have just what you are looking for.

The FDA Orange Book has been the definitive drug resource for many years, and now there is an electronic version of the book available to the public. The manual provides data about drug patents and available generic versions of name brand drugs. This information can be crucial in helping doctors determine what method of treatment may be best for a patient.

Ferrer, Poirot & Wansbrough is hopeful the online version of the book provides people with more accessible information about the medications prescribed to them.

Bookmark and Share

Antibiotic Ceftriaxone Linked to Acute Renal Failure in Children

by Keith Adkins | April 1st, 2014

April 1, 2014

Antibiotics can help us overcome many illnesses, but some types of these drugs have been linked to adverse health events and Antibiotic Drug Injuries. Most recently, a study discovered that the use of Ceftriaxone in children could lead to acute renal failure.

The study was released in the latest issue of the peer-reviewed journal, Pediatrics, and examined the cases of 31 patients treated using Ceftriaxone between 2003 and 2011. The team of researchers found that acute renal failure could be caused in as little as 5.2 days. While many of the patients were able to recover with further treatment, some required catheters. Others needed hemodialysis in order to overcome health issues caused by the medication.

The study leaves many wondering what they can do to prevent harm if they take antibiotics. Researchers stated that anyone experiencing flank pain or the onset of anuria should seek medical treatment immediately.

The Drug Injury Attorneys with Ferrer, Poirot, and Wansbrough also encourage anyone harmed by a medication to discuss their legal rights with a qualified attorney.


Bookmark and Share

Chemotherapy Drugs Increases Risk of Heart Disease in Cancer Survivors

by Keith Adkins | March 25th, 2014

March 25, 2014

Sometimes the drugs we use can do more harm that good by causing serious Drug Injuries. A fine example of this is a recent study that was released on the long-term effects chemotherapy drugs and radiation treatments may have on cancer patients. Researchers found that while these medications and treatments may be effective in eradicating cancer from the body, they may also be causing serious harm to patients’ heart tissue.

Studies show those undergoing cancer treatment are three times as likely to develop cardiac problems as those not undergoing treatment. In fact, heart disease is the leading cause of death among cancer survivors.

So, what is being done to develop a solution to this problem? An article from Harvard University states the issue has given rise to a new field of study, called cardio-oncology. Individuals studying in the field are working to reduce the impact of cancer treatment on patients’ hearts.

The Drug Injury Lawyers with Ferrer, Poirot & Wansbrough are hopeful to see a development made that would eliminate the risks of adverse cardiovascular events with cancer treatments.

Bookmark and Share

Anesthesia Care Computer System Recalled Over Deadly Glitch

by Keith Adkins | March 18th, 2014

March 18, 2014

Some of the most serious cases of drug injuries occur when the wrong medication or dosage of a drug is given to patients. In some instances, these mistakes could be the result of hospital equipment malfunctions.

The Defective Medical Device Lawyers with Ferrer, Poirot & Wansbrough explain such a situation is why San Francisco-based manufacturer, McKesson Technologies, has recalled its Anesthesia Care computer system.

According to an article from Mass Device, the affected units can have system glitches that cause data to be correlated with the wrong patient. The systems collect data about patients from monitors while a procedure is being performed, especially while the patient is under anesthesia. Reports indicate the units may mismatch the data that is collected with the correct patient case data.

These errors have so far been associated with harm to at least one patient and prompted the U.S. Food and Drug Administration (FDA) to issue a Class 1 recall due to the risk of death associated with the errors.

Problems like this leave many citizens wondering what they should do if they are harmed by a defective medical device. The attorneys with Ferrer, Poirot & Wansbrough explain you should:

  • Seek the medical attention you need.
  • Report the problem to your doctor and the FDA.
  • Discuss your legal rights and options with a reputable attorney.
Bookmark and Share

Petition Demands Accountability From Generic and Brand Name Drug Manufacturers

by Keith Adkins | March 11th, 2014

March 11, 2014

Millions of Americans depend on medications to treat their conditions and ailments. For many, purchasing generic versions of brand name medications is one way to keep medical costs down. In fact, 80 percent of prescriptions are filled using a generic form of a drug. But doing so may put consumers at risk, because makers of generic and brand name medications are held to different safety standards under current U.S. law.

Similar brand name and generic drugs are required to carry the same warning label. However, if a risk of harm is discovered after the drug’s release, the generic drug makers cannot change a warning label until the brand name manufacturer makes the change. The rule also prevents generic drug manufacturers from being held accountable in court when a generic drug is responsible for harming a patient.

The Drug Injury Attorneys with Ferrer, Poirot & Wansbrough believe manufacturers of both generic and brand name medications should be held accountable for the harm caused by their products. That is why the firm is asking citizens to call on the U.S. Food and Drug Administration (FDA) to take action against this problem.

Take Justice Back is hoping to raise enough signatures on a petition demanding the FDA hold generic drug manufacturers to the same warning label standards brand name makers face.

The attorneys with Ferrer, Poirot & Wansbrough ask that each citizen demand accountability from all drug manufacturers by signing the petition for change.

Bookmark and Share

New Opioid Painkiller Approved Despite Objections From Officials and Experts

by Keith Adkins | March 4th, 2014

March 4, 2014

Opioid painkillers can be extremely beneficial in treating patients suffering from excruciating pain, but the potential for deadly dosage errors makes the use of these medications extremely risky. Now, experts are concerned a new, more powerful form of these drugs approved by the U.S. Food and Drug Administration (FDA) may present a Painkiller Overdose risk.

An article from RT News stated the new drug, called Zohydro, is as much as 10 times stronger than Vicodin and packs more punch than Oxycontin, the strongest painkiller on the market today. Experts say patients who are not used to taking this type of medication and consume two capsules could die, while children could suffer fatal overdoses after taking just one pill.

Such a powerful narcotic medication may fuel the epidemic of painkiller overdoses the United States is currently experiencing. Studies have shown taking too much of an opioid medication is the number one drug injury reported in the United States today.

These findings have prompted a group of more than 40 doctors to call on the FDA to reconsider its approval of the drug. Several members of Congress and attorney generals from 28 states are also calling for the reconsideration.

The Drug Injury Attorneys with Ferrer, Poirot & Wansbrough hope the FDA makes a decision that best protects patient safety and health.

Bookmark and Share

Supplement Is Recalled Due to Ingredient Mix-Up

by Keith Adkins | February 25th, 2014

February 25, 2014

The U.S Food and Drug Administration (FDA) recently announced the voluntary recall of a medication used to treat children suffering genetic disorders. The recall was initiated due to the medications containing the wrong ingredients.

An FDA Press Release stated drug manufacturer Medisca’s L-citrulline supplement can be used to treat children suffering from certain genetic disorders and has been shown to be effective in treating erectile dysfunction during trials. However, testing by FDA investigators showed several lots of the drug did not contain the active ingredient at all. Instead, the medications contained N-Acetyl-leucine, a compound that is used to treat patients afflicted with vertigo.

Experts say that such a mistake could not only cause a patient serious harm if the affected medications are taken, it may also result in death.

That is why the FDA is asking any doctors or medical facilities in possession of the affected medications to quarantine them immediately. Anyone harmed by the affected medications should report the incident to the FDA immediately.

The Drug Injury Attorneys with Ferrer, Poirot & Wansbrough would also encourage anyone who has been injured by the affected supplement to discuss their legal options with an attorney immediately in order to help protect any potential rights to compensation.


Bookmark and Share

Pradaxa Lawsuits Show Drug Manufacturer May Have Hidden Research

by Keith Adkins | February 18th, 2014

February 18, 2014

Drug manufacturers have a responsibility to ensure the safety of medications they release to the market. Failure to do so can result in patients suffering serious harm, which can lead to lawsuits being filed against the drug maker for damages.

Such a case has been filed in connection to patients suffering a specific Pradaxa Drug Injury, allegedly because the company who made the product failed to warn consumers of certain risks associated with the drug. Now, court documents are showing research that showed the dangers of Pradaxa may have been withheld due to the fact it could harm the marketability of the drug.

An article from the New York Times states the medication was one of several drugs looking to fill a gap in the market for medications used to prevent blood clots from forming in the body. The manufacturer stated it was a better blood clot treatment, as it did not require constant monitoring of blood levels to ensure proper levels of the drugs were being absorbed into the body.

The medication was distributed to 850,000 patients and resulted in an estimated 1,000 deaths due to a risk of uncontrollable bleeding associated with the drug. Lawsuits were filed in connection to the accidents.

Now, court documents are showing researchers may have knew about the dangers, but drug manufacturer executives may have hidden the results. The company has denied the allegations.

The Drug Injury Attorneys with Ferrer, Poirot & Wansbrough recognize the dangers posed by drug manufacturers withholding vital information about a product and are here to help anyone who has been harmed as the result of taking a medication prescribed by a doctor.


Bookmark and Share

“Dallas Buyers Club” Underscores Problems in Drug Approval Process

by Keith Adkins | February 11th, 2014

February 11, 2014

The U.S. Food and Drug Administration (FDA) is charged with the job of evaluating drug safety and approving medications to be used by patients in the United States. The Drug Injury Attorneys with Ferrer, Poirot & Wansbrough explain that some drugs are approved based on legal loopholes while more helpful medications may be overlooked.

This is an underlying theme in the film Dallas Buyers Club. The movie tells the true story of Ron Woodruff, an electrician living with AIDS/HIV during the mid-1980’s. The character is told by doctors he only has one month to live, which sets him on a course to find a medication that can save his life. He finds drugs and supplements that help alleviate the symptoms of his condition, but he is unable to get the products in the United States because they are not FDA approved. Woodruff smuggles the compounds back to the United States in bulk, so he can distribute them to other patients. Rather than sell the supplements and medications, he uses a membership system that grants free access to the drugs and allows him to avoid criminal prosecution.

The drugs and supplements were not approved by the FDA because of high costs and because drug manufacturing companies were attempting to push another medication through the approval process. In fact, the film shows where trials determine too much of the manufacturer’s drug is lethal to patients, unlike the medications supplied by Woodruff .

Unfortunately, the FDA’s failure to approve the treatment likely cost many lives, and the attorneys with Ferrer, Poirot & Wansbrough feel action should be taken to ensure United States citizens have access to the safest and best drugs in the world.

Bookmark and Share